Advisory - One lot of the antidepressant drug APO-Amitriptyline recalled because of nitrosamine impurity
Retrieved on:
Saturday, April 17, 2021
This means that long-term exposure to a level above what is considered safe may increase the risk of cancer.
Key Points:
- This means that long-term exposure to a level above what is considered safe may increase the risk of cancer.
- NDMA is not expected to cause harm when ingested at at or below the acceptable level.
- As this recall affects only one lot, patients are not expected to be exposed to levels of NDMA that exceed safe levels for an extended period of time.
- Should any additional recalls be deemed necessary, Health Canada will update the table below and inform Canadians.\n"